The Ellen L. Stovall Award for
Innovation in Patient-Centered Cancer Care
Meet the 2019 Stovall Award Honorees
“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”
—Karen M. Saunders
President, Northeast Regional Cancer Institute
Dr. Brereton is a graduate from Yale University and earned a medical degree from the University of Pittsburgh. Subsequent training in Internal Medicine took him to Emory University in Atlanta, Georgia. Dr. Brereton spent the next six years at the National Cancer Institute doing clinical and basic research and obtained certification in both Medical Oncology and Hematology. He completed additional training at Johns Hopkins for Radiation Oncology and was board certified.
Dr. Brereton served on the staff at Georgetown University for two years and then entered private practice where he spent thirty-three years developing cancer services by founding the Northeast Regional Cancer Institute in his community of Scranton, Pennsylvania. At the end of his private practice career, he was involved in the development of a new school, The Commonwealth Medical College, now the Geisinger Commonwealth School of Medicine, where he continues to serve on the faculty as a Clinical Professor of Medicine. In addition to also teaching at the Weill Cornell School of Medicine, he is also a leadership team member of the International Cancer Expert Corps.
“Patient reimbursements and engagement are key, and Ms. Dornsife had the vision to understand that and the leadership to make it happen. Lazarex provides a key to hope…a key to life. I cherish every moment with my grandkids and my daughters, and I get that opportunity because of Dana Dornsife.”
Stage 4 Metastatic Breast Cancer Patient
Dana Dornsife is Chair of the Board and Founder of Lazarex Cancer Foundation, a nationwide public non-profit organization she began in 2006. The unique mission of Lazarex is to improve the outcome of cancer care—giving hope, dignity and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and engagement.
Dana has recently expanded the mission at Lazarex to bring transformational change to the bench to bedside process of clinical trial enrollment, retention, minority participation and equitable access with IMPACT (IMproving Patient Access to Cancer Clinical Trials). She is a graduate of Drexel University in Philadelphia and serves as a board member of the USC Brain and Creativity Institute at University of Southern California, the UCSF Cancer Leadership Council, and the MGH Presidents Council.
About Ellen Stovall
In more than two decades of service and leadership at the National Coalition for Cancer Survivorship (NCCS), Ellen L. Stovall crusaded for the delivery of quality cancer care to all Americans. As a cancer survivor of more than four decades, Ellen sought to design her own system of patient-centered care to address the serious late and long-term effects of her cancer treatment, including the treatment of a second cancer. In pursuing her own system of care, she focused on care that emphasized strong doctor-patient communication, coordination of care and symptom management, and full consideration of the evidence supporting treatment options.
Ellen considered herself a “lucky” cancer survivor because her advocacy for herself opened the door to some of the best of American cancer care, accompanied by some of the glitches and gaps in care that many experience. Ellen’s pursuit of her own quality cancer care informed NCCS efforts to improve the overall cancer care delivery and payment system. Ellen and her colleagues at NCCS pursued changes in public and private payment systems that would encourage cancer care professionals to provide patient-centered care through partnership with their patients and through redesign of their systems to honor the principles of patient-centeredness.